ANI Pharmaceuticals logo
ANI Pharmaceuticals ANIP
$ 56.32 -3.21%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

ANI Pharmaceuticals Balance Sheet 2011-2024 | ANIP

Annual Balance Sheet ANI Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

65.3 M 238 M 187 M 178 M 123 M 140 M 170 M 93.3 M -41.3 M -58.3 M -11.1 M -26.9 M -39.9 M

Long Term Debt

285 M 286 M 287 M 172 M 176 M 67.3 M 198 M 121 M 113 M 111 M - - 17.3 M

Long Term Debt Current

1.56 M 850 K 850 K 13.2 M 9.94 M 3.26 M 3.35 M - - - - - -

Total Non Current Liabilities

- - - - 182 M 67.8 M 198 M 121 M 113 M 111 M - - 17.3 M

Total Current Liabilities

145 M 99.4 M 87.5 M 78.6 M 61.7 M 166 M 39.2 M 31.9 M 11.8 M 13.2 M 3.54 M 10.6 M 7.23 M

Total Liabilities

447 M 422 M 413 M 265 M 244 M 233 M 237 M 153 M 125 M 124 M 3.54 M 10.6 M 24.6 M

Deferred Revenue

- - - 80 K 451 K 711 K - - - - 47 K - -

Retained Earnings

-80.1 M -97.3 M -47.8 M -4.97 M 17.6 M 11.5 M -4.01 M -2.92 M -4.35 M -19.7 M -48.5 M -245 M -217 M

Total Assets

904 M 760 M 772 M 461 M 457 M 431 M 412 M 323 M 285 M 264 M 44.5 M 38.8 M 62.4 M

Cash and Cash Equivalents

221 M 48.2 M 100 M 7.86 M 62.3 M 43 M 31.1 M 27.4 M 155 M 169 M 11.1 M 11 K 57.2 M

Book Value

458 M 339 M 359 M 196 M 213 M 197 M 175 M 170 M 160 M 140 M 41 M 28.2 M 37.8 M

Total Shareholders Equity

433 M 314 M 334 M 196 M 213 M 197 M 175 M 170 M 160 M 140 M 41 M -42.7 M 37.8 M

All numbers in USD currency

Quarterly Balance Sheet ANI Pharmaceuticals

2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

284 M 285 M 285 M 285 M 286 M 286 M 286 M 286 M 287 M 186 M 190 M 169 M 172 M 172 M 172 M 172 M 176 M 176 M 176 M 176 M 67.3 M 67.3 M 67.3 M 67.3 M 69.9 M 69.9 M 69.9 M 69.9 M - 121 M 121 M 121 M 113 M 113 M 113 M 113 M 107 M 111 M 111 M 111 M - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

440 M 435 M 425 M 426 M 422 M 402 M 414 M 399 M 413 M 279 M 288 M 260 M 265 M 265 M 265 M 265 M 244 M 244 M 244 M 244 M 233 M 233 M 233 M 233 M 237 M 237 M 237 M 237 M 153 M 153 M 153 M 153 M 125 M 125 M 125 M 125 M 120 M 124 M 124 M 124 M 3.54 M - - 9.33 M 10.6 M 10.9 M 16.4 M 16.6 M 24.6 M 24.6 M 24.6 M 24.6 M

Deferred Revenue

- - - - - - - 116 K 87 K 62 K 62 K 62 K 80 K 80 K 80 K 318 K 451 K 451 K 558 K 624 K 711 K 735 K 711 K 711 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-65 M -80.9 M -90.4 M -96.3 M -97.3 M -92.6 M -83.6 M -68.3 M -47.8 M -23.4 M -19 M -4.89 M -4.97 M -4.97 M -4.97 M -4.97 M 17.6 M 17.6 M 17.6 M 17.6 M 11.5 M 11.5 M 11.5 M 11.5 M -4.01 M -4.01 M -4.01 M -4.01 M -2.92 M -2.92 M -2.92 M -2.92 M -4.35 M -4.35 M -4.35 M -4.35 M -19.7 M -19.7 M -19.7 M -19.7 M -48.5 M -48.5 M -48.5 M -48.5 M -43.8 M -43.8 M -43.8 M -245 M -217 M -217 M -217 M -217 M

Total Assets

921 M 890 M 859 M 765 M 760 M 739 M 751 M 745 M 772 M 470 M 480 M 464 M 461 M 461 M 461 M 461 M 457 M 457 M 457 M 457 M 431 M 431 M 431 M 431 M 412 M 412 M 412 M 412 M 323 M 323 M 323 M 323 M 285 M 285 M 285 M 285 M 260 M 264 M 264 M 264 M 44.5 M 44.5 M 44.5 M 44.5 M 13.7 M 13.7 M 13.7 M 38.8 M 62.4 M 62.4 M 62.4 M 62.4 M

Cash and Cash Equivalents

240 M 193 M 162 M 67.8 M 48.2 M 56.3 M 63.4 M 76.9 M 100 M 15.3 M 24.3 M 25.1 M 7.86 M 7.86 M 7.86 M 7.86 M 62.3 M 62.3 M 62.3 M 62.3 M 43 M 43 M 43 M 43 M 31.1 M 31.1 M 31.1 M 31.1 M 27.4 M 27.4 M 27.4 M 27.4 M 155 M 155 M 155 M 155 M 169 M 169 M 169 M 169 M 11.1 M 11.1 M 11.1 M 11.1 M 11 K 11 K 11 K 34.8 M - 57.2 M 57.2 M 57.2 M

Book Value

481 M 455 M 434 M 339 M 339 M 337 M 337 M 346 M 359 M 191 M 192 M 204 M 196 M 196 M 196 M 196 M 213 M 213 M 213 M 213 M 197 M 197 M 197 M 197 M 175 M 175 M 175 M 175 M 170 M 170 M 170 M 170 M 160 M 160 M 160 M 160 M 140 M 140 M 140 M 140 M 41 M 44.5 M 44.5 M 35.2 M 3.15 M 2.83 M -2.63 M 22.2 M 37.8 M 37.8 M 37.8 M 37.8 M

Total Shareholders Equity

456 M 430 M 410 M 315 M 314 M 312 M 312 M 321 M 334 M 191 M 192 M 204 M 196 M 196 M 196 M 196 M 213 M 213 M 213 M 213 M 197 M 197 M 197 M 197 M 175 M 175 M 175 M 175 M 170 M 170 M 170 M 170 M 160 M 160 M 160 M 160 M 140 M 140 M 140 M 140 M 41 M 41 M 41 M 41 M -42.7 M -42.7 M -42.7 M 28.2 M -34.3 M 37.8 M 37.8 M 37.8 M

All numbers in USD currency